학술논문
Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML
Document Type
Article
Author
Source
In: Translational Oncology . (Translational Oncology, April 2022, 18)
Subject
Language
English
ISSN
19365233